Atlas Trials

Micronised Resveratrol as a Treatment for Friedreich Ataxia

Clinical trial NCT03933163 · COMPLETED

Trial details

NCT number
NCT03933163
Sponsor
Murdoch Childrens Research Institute
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Friedreich Ataxia
Start date
2019-05-23
Primary completion
2024-03-28
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.